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A B S T R A C T
Objective: Former studies in chronic diseases showed the importance of patients’ beliefs and perceptions.
The Revised Illness Perception Questionnaire was developed to assess these illness perceptions. Our goal
was to investigate psychometric properties of the IPQ-R for Fibromyalgia Dutch language version (IPQ-R
FM-Dlv) and to describe illness perceptions of participants with FM.
Methods: 196 patients completed the IPQ-R FM-Dlv. Internal consistency, domain structure and inter
domain correlations were calculated and compared to the IPQ-R English language version. Scores were
compared with chronic fatigue syndrome (CFS), rheumatoid arthritis (RA), and coronary heart disease
(CHD).
Results: Most psychometric properties were comparable to those of the original IPQ-R. Participants
showed a lack of understanding of their illness, expected their FM to be chronic and to have a lot of
negative consequences on functioning. In 17 out of 24 domains signiﬁcant differences were found
between FM and CFS, RA, and CHD patients.
Conclusion: The IPQ-R FM-Dlv showed acceptable psychometric properties, although some aspects need
closer examination. Illness perceptions of FM patients on the Dutch questionnaire were non-comparable
to CFS, RA, and CHD patients on the English questionnaire.
Practice implications: The IPQ-R FM-Dlv can be used to assess illness perceptions of Dutch FM patients.
 2008 Elsevier Ireland Ltd. All rights reserved.
Contents lists available at ScienceDirect
Patient Education and Counseling
journa l homepage: www.e lsev ier .com/ locate /pateducou1. Introduction
Fibromyalgia is characterized by widespread musculoskeletal
pain of at least three months’ duration, fatigue, poor sleep and
tenderness on palpation in at least 11 of 18 speciﬁc tender point
sites [1]. The etiology of ﬁbromyalgia syndrome is still unknown
[2–4]. Its’ diagnosis is primarily based on exclusion, established
only after other causes of joint or muscle pain are ruled out [4]. For
the majority of patients the localized long-standing muscle pain
gradually spreads to multiple sites and becomes continuous. The
prevalence of ﬁbromyalgia in theWesternworldmost likely ranges
from 2 to 3% with particularly high prevalence rates in women and
in age groups of 55–64 years [3,5–7]. Fibromyalgia is related to a
poor quality of life and sustained disability [8–12].* Corresponding author. Tel.: +31 50 5957728.
E-mail address: m.w.van.ittersum@pl.hanze.nl (M.W. van Ittersum).
0738-3991/$ – see front matter  2008 Elsevier Ireland Ltd. All rights reserved.
doi:10.1016/j.pec.2008.07.041For ﬁbromyalgia some risk factors are known; female gender,
low level of income, living in a socially comprised housing area,
depression, anxiety and panic disorder [3,13–16]. Beliefs or
perceptions about pain may inﬂuence experienced pain intensity
[17–19]. Several studies found that patients who have catastro-
phical illness perceptions experiencemore pain, feelmore disabled
by their pain, suffer more psychological distress and have poor
outcomes of pain treatment [20–24]. Possible explanations for this
relation range from an increased attention to pain and heightened
emotional responses to pain to direct ampliﬁcation of the central
nervous system’s processing of pain causing inactivity which
might result in diminished function and increased pain [21,22,24].
Spinhoven et al. [23] found that a reduction of negative illness
perceptions mediated the reduction of depression and reduced
pain behavior in patients with chronic low back pain. Another
study found better treatment outcome in patients with more
positive illness perceptions like believing to have control over pain,
believing that one is not necessarily disabled by ﬁbromyalgia and
M.W. van Ittersum et al. / Patient Education and Counseling 74 (2009) 53–6054that pain is not necessarily a sign of damage, compared to patients
with negative illness perceptions [25].
To analyze illness perceptions, Leventhal et al. [26] developed a
self-regulatory model describing how patients construct their own
representations of illness perceptions. The ﬁve core components of
this model are beliefs about the etiology of the illness, its
symptoms and label, the personal consequences of the illness,
how long it will last, and the extent to which the illness is
amenable to control by the patient or to cure [27,28]. The Illness
Perception Questionnaire (IPQ) was developed to provide a
quantitative assessment of these representations of illness
perceptions. A few years later a revised version of the ques-
tionnaire was constructed: the Revised Illness Perception Ques-
tionnaire (IPQ-R), in which some items were restructured and new
items were added [28]. Several studies provide support for the
structural relations between the ﬁve components of illness
representation described by Leventhal, and for the expected links
between illness perceptions and a range of psychological out-
comes, and between illness perceptions and functional adaptation
[29–31]. The IPQ-R has been described in patients with chronic
diseases such as coronary heart disease (CHD), chronic fatigue
syndrome (CFS), and rheumatoid arthritis (RA) [32,33].
In order for the IPQ-R to be useful in patients with ﬁbromyalgia,
information about the psychometric properties in this patient
group is essential. Therefore, the purpose of this study was to
describe the psychometric properties of the Revised Illness
Perception Questionnaire for Fibromyalgia Dutch language version
(IPQ-R FM-Dlv), compared to the English language version, and to
describe illness perceptions in patientswith ﬁbromyalgia using the
IPQ-R FM-Dlv. For a better understanding of the illness perceptions
in patients with FM, the illness perceptions of our patient group




Participants were recruited from a physical therapy treatment
center. The center provided a list of all ﬁbromyalgia patients that
had visited the center at least once in the last 15 years. Participants
were selected from this list according to the following criteria:
diagnosedwith ﬁbromyalgia according to the ACR criteria, age18
years and experiencing pain from FM at the time they completed
the survey. A total of 322 ﬁbromyalgia patients were eligible to the
study. These patients were sent a letter containing information
about the study, inwhich theywere asked to participate, and asked
for informed consent. Two hundred ﬁfty patients gave informed
consent, they received the questionnaire that could be returned by
mail. Finally 196 patients (response rate 61%) returned the
questionnaire and were included in the study.
2.2. Questionnaire
The questionnaire consists of two parts. The ﬁrst part asks for
general information like gender, age and marital status and
information about the duration of ﬁbromyalgia and medication
use. Also a Visual Analogue Scale (VAS) is used to rate perceived
pain, perceived stiffness and perceived fatigue at the moment. The
second part consists of the IPQ-R FM-Dlv.
The original IPQ-R English language version consists of nine
domains. The ﬁrst domain is the illness identity scale, which
consists of 14 commonly experienced symptoms. Subjects are
asked to rate whether or not they have experienced each symptom
since their illness. They are then asked whether or not they believethe symptom to be speciﬁcally related to their illness. The score on
the identity domain is the sum of the yes-rated items on this
second question. The following seven domains of the IPQ-R are
scored on a 5-point Likert type scale (1–5): strongly disagree,
disagree, neither agree nor disagree, agree and strongly agree.
These domains include timeline acute/chronic (perceptions of
likely chronic duration of the health problems); timeline cyclical
(perceptions of likely variability of the health problems over time);
consequences (beliefs about illness severity and impact on
physical, social and psychological functioning); personal control
(belief in personal control over the illness); treatment control
(belief in cure through treatment); illness coherence (how much
patients comprehend or understand their illness); and emotional
representations (perception of negative emotions generated by the
illness) (see Table 2). High scores on the identity, timeline,
consequences, and cyclical domains represent a negative view of
the illness. High scores on the personal control, treatment control
and coherence domains, represent positive beliefs about the
controllability of the illness and a personal understanding of the
condition. Finally, the causal domain is presented as a separate
section. It consists of 18 attributional items, which are scored on
the same Likert type scale. The causal domain can be divided into 4
sub domains: psychological attributions, risk factors, immunity
and accident or chance [28].
The IPQ-R English language version was shown to give good
internal reliability of the domains, good short and longer term
retest reliability and sound discriminant, known group and
predictive validity in a study population consisting of patients
with a variety of diseases (asthma, diabetes, rheumatoid arthritis,
acute pain, chronic pain, myocardial infarction, multiple sclerosis
(all from Auckland, New Zealand) and HIV (from Brighton, United
Kingdom)) [28].
For constructing the IPQ-R FM-Dlv Moss-Morris’s IPQ-R was
adapted by changing ‘my illness’ into ‘my ﬁbromyalgia’. The
English language version for rheumatoid arthritis and the Dutch
language version for diabetes were used as examples
[www.uib.no/ipq].
2.3. Statistical analysis
Data were analyzed using SPSS-11.5.0. For the ﬁrst objective of
this study, to assess psychometric properties of the Dutch language
version of the IPQ-R for ﬁbromyalgia, internal consistency, domain
structure and inter domain correlations were calculated. To
express the internal consistency of the different items in the
domains of the IPQ-R FM-Dlv, Cronbach’s alphas were calculated.
Cronbach’s alpha expresses the association between the different
items in a certain domain. A Cronbach’s alpha above 0.70 is
considered to be acceptable for the use of questionnaires on group
level [34].
The Multiple Group Method (MGM) [35], a simple type of
conﬁrmatory factor analysis, was used to validatewhether the data
supported the categorization of items into the domains identiﬁed
for the original English language version of the IPQ-R. In the MGM,
domain scores were created by taking sums of the items that were
a priori assigned to the domains. Next, correlationswere computed
between the items and the domains of the IPQ-R. For items
included in a domain, the correlation coefﬁcients were corrected
for ‘‘self-correlation’’, that is, the fact that items automatically
correlate high with components in which they take part. Also a
correction for test-length was included. Finally, we veriﬁed that
the items indeed correlated strongest with the domain to which
they were assigned to on theoretical grounds. It was assumed that
factor structures are supported when items correlated strongest
with the domain they were assigned to in the original version of
Table 1
General characteristics of the participants with ﬁbromyalgia
Study population
Number of participants 196
Men/women (%) 12/88












Mean (S.D.) years with symptoms 15 (10)
Mean (S.D.) years diagnosed with FM 7 (6)
Median (min–max) VAS pain at this moment (0–10) 7 (1–10)
Median (min–max) VAS stiffness at this moment (0–10) 9 (1–10)
Median (min–max) VAS fatigue at this moment (0–10) 9 (1–10)
a Sum > 100% because more than one answer was possible.
b >1 year of sickness absenteeism.
able 2
lness Identity domain of the IPQ-R; 14 commonly experienced symptoms




I perceive this symptom as





tiff joints 87 85
oss of strength 78 82
leep difﬁculties 68 62
pset stomach 63 46
eadaches 54 32





ore throat 21 6
Weight loss 15 12
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items in the ‘beliefs domains’ and second for the items in the four
attributional domains of the questionnaire.
Validity of the range of symptoms included in the Illness
identity domain was investigated by assessing the frequencies
with which the different symptoms were endorsed as part of
patients’ illness identity. All the symptoms should at least be
endorsed once for acceptable validity [28].
Inter domain correlations were investigated by computing
Pearson’s correlation coefﬁcients between the domains of the
questionnaire. Internal consistency, domain structure and the inter
domain correlations of the IPQ-R FM-Dlv were compared to scores
of the well-validated IPQ-R English language version in a large
mixed patient group.
To describe illness perceptions in Dutch ﬁbromyalgia patients
and to compare these with illness perceptions in other patient
groups, means and S.E.’s on the different domains for Dutch
ﬁbromyalgia patients were calculated and compared to data of
studies by Moss-Morris and Chalder [32] and Byrne et al. [33] in
chronic fatigue syndrome (CFS), rheumatoid arthritis (RA) and
coronary heart disease (CHD). Conﬁdence Intervals for the
differences between the means were calculated.
3. Results
With a response rate of 61%, a total of 196 patients participated
in this study. Due to anonymity of data, information of non-
responders was not available.
General characteristics of those participating in this study are
shown in Table 1. In this group 64% used medication for their
ﬁbromyalgia. All participants experienced pain, fatigue and
stiffness from their FM at the time they completed the survey.
For the Illness identity domain the frequencies with which
symptoms were endorsed as part of FM were investigated. All
symptoms were endorsed by at least 6% of the participants,
conﬁrming the validity of the range of symptoms included in the
identity domain. Table 2 shows the results on the Illness identity
domain of IPQ-R FM.
The internal consistency of the IPQ-R FM-Dlv was calculated
and compared to the internal consistency of the IPQ-R English
language version, see Table 3. On all domains Cronbach’s alpha of
the IPQ-R FM are0.75. Of the four sub domains within the Causes
domain only Psychological attributions presents an alpha >0.70.
The sub domain Accident or chance shows a very low internal
consistency. All Cronbach’s alphas of IPQ-R FM are slightly lower
than those of the original IPQ-R.
The factors of the MGM analysis of the ‘beliefs’ items accounted
for 55% of the variance. On the two timeline domains, con-
sequences, and illness coherence domains strongest item correla-
tions are as expected, conﬁrming the a priori allocation of the items
in these domains of the IPQ-R FM. Four items have a stronger
correlation with one of the other domains of the Dutch IPQ-R than
with the domain they were a priori assigned to. However, these
four items also correlate relatively strong (but not strongest) with
the expected domains (Table 3a).
In the second MGM (Table 3b) the observed variance that is
explained by the tested item grouping is 50%. The division of the
items in the psychological attributions sub domain and the
immunity sub domain of the questionnaire are as expected,
the categorization of items in the other two attributional sub
domains could not be conﬁrmed.
In the comparison of the inter-relationships between the
domains of the IPQ-R FM-Dlv to those of the English language
version of the questionnaire similarities but also some differences
were found, see Table 4 in which the inter domain correlations forthe original English version of the questionnaire in a large sample
(N = 711) of eight different illness groups is presented above the
diagonal. For example, several correlations in the consequences
and treatment control domains and in the attributional domains
are identical in the two versions. Nevertheless, in 13 out of 66
cases, correlation coefﬁcients differmore than .20 between the two
questionnaires. Only a few strong (r  .50) correlations were
found. Strong correlations in both questionnaires were found for
personal control and treatment control, consequences and
emotional representations and between psychological and risk
factor attributions. The other three strong inter domain correla-
tions in the original version of the questionnaire (between timeline
acute/chronic and consequences, between personal control and
illness coherence and between treatment control and illness
coherence) were moderate or even low in the IPQ-R Dlv.
Most relations between domains of the IPQ-FM are as expected
in patients with ﬁbromyalgia (Table 4). The belief that the illness is
severe and has a strong impact on psychosocial, economic and
physical functioning (consequences) is related to the belief that
more symptoms are speciﬁcally related to FM (illness identity), a
stronger belief in the chronic course of FM (timeline acute/chronic)
















Cronbach’s alphas and corrected correlations (Multiple Group Method) of the items in the ‘beliefs’ domains of IPQ-R FM-Dlv
1. 2. 3. 4. 5. 6. 7.
1. Timeline acute/chronic a = 0.89, a = 0.80
My FM will last a short time* 0.390 0.053 0.133 0.027 0.110 0.017 0.118
My FM is likely to be permanent rather than temporary 0.511 0.035 0.159 0.121 0.042 0.044 0.044
My FM will last for a long time 0.417 0.067 0.128 0.012 0.067 0.082 0.034
My FM will pass quickly* 0.397 0.083 0.131 0.030 0.056 0.021 0.086
I expect to have my FM for the rest of my life 0.420 0.001 0.165 0.034 0.110 0.074 0.053
My FM will improve in time* 0.339 0.022 0.073 0.174 0.269 0.008 0.110
2. Timeline cyclical a = 0.79, a = 0.75
The symptoms of my FM change a great deal from day to day 0.041 0.375 0.022 0.037 0.053 0.047 0.012
My symptoms come and go in cycles 0.019 0.477 0.027 0.089 0.108 0.026 0.009
My FM is very unpredictable 0.161 0.420 0.075 0.002 0.045 0.101 0.134
I go through cycles in which my FM gets worse and better 0.072 0.425 0.021 0.082 0.115 0.058 0.008
3. Consequences a = 0.84, a = 0.77
My FM is a serious condition 0.211 0.031 0.313 0.077 0.116 0.104 0.261
My FM has major consequences in my life 0.200 0.157 0.422 0.082 0.162 0.097 0.273
My FM does not have much effect on my life* 0.213 0.048 0.381 0.005 0.039 0.059 0.223
My FM strongly affects the way others see me 0.082 0.089 0.358 0.094 0.180 0.105 0.277
My FM has serious ﬁnancial consequences 0.071 0.008 0.347 0.090 0.098 0.075 0.190
My FM causes difﬁculties for those who are close to me 0.011 0.102 0.355 0.146 0.161 0.015 0.279
4. Personal control a = 0.81, a = 0.77
There is a lot which I can do to control my symptoms 0.091 0.035 0.137 0.353 0.273 0.150 0.166
What I do can determine whether my FM gets better or worse 0.053 0.107 0.158 0.294 0.371 0.137 0.167
The course of my FM depends on me 0.140 0.050 0.166 0.309 0.273 0.033 0.123
Nothing I do will affect my FM* 0.016 0.002 0.001 0.270 0.086 0.042 0.067
I have the power to inﬂuence my FM 0.013 0.041 0.073 0.336 0.320 0.115 0.096
My actions will have no effect on the outcome of my FM* 0.020 0.038 0.040 0.243 0.096 0.138 0.070
5. Treatment control a = 0.80, a = 0.79
There is very little that can be done to improve my FM* 0.141 0.008 0.240 0.177 0.390 0.155 0.206
Treatment will be effective in curing my FM 0.121 0.105 0.043 0.356 0.344 0.104 0.088
The negative effects of my FM can be prevented (avoided) by my treatment 0.101 0.149 0.151 0.198 0.381 0.100 0.109
Treatment can control my FM 0.093 0.116 0.131 0.237 0.390 0.179 0.086
There is nothing which can help my FM* 0.089 0.071 0.064 0.214 0.338 0.066 0.148
6. Illness coherence a = 0.87, a = 0.79
The symptoms of my FM are puzzling to me* 0.056 0.121 0.045 0.114 0.104 0.565 0.220
My FM is a mystery to me* 0.085 0.039 0.059 0.156 0.153 0.581 0.244
I don’t understand my FM* 0.026 0.092 0.098 0.050 0.113 0.525 0.199
I have a clear picture or understanding of my FM 0.027 0.021 0.101 0.091 0.114 0.418 0.152
7. Emotional representations a = 0.88, a = 0.81
I get depressed when I think about my FM 0.024 0.027 0.168 0.071 0.116 0.213 0.383
When I think about my FM I get upset 0.004 0.062 0.216 0.174 0.097 0.162 0.468
My FM makes me feel angry 0.131 0.086 0.387 0.145 0.193 0.141 0.382
My FM does not worry me* 0.107 0.061 0.135 0.133 0.128 0.185 0.176
Having this FM makes me feel anxious 0.084 0.043 0.299 0.067 0.114 0.273 0.497
My FM makes me feel afraid 0.095 0.023 0.298 0.099 0.116 0.249 0.476
Cronbach’s alphas in italic script are from the IPQ-R English language version in amixed patient group (Moss-Morris et al. [28]), Cronbach’s alphas in bold script from the IPQ-
R FM-Dlv, *denotes items reverse scored, the highest corrected correlations are presented in bold script.
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related to FM (illness identity) is related to the belief that there is
notmuch the person can do to control the illness (personal control)
and with less conﬁdence in the effect of treatment (treatment
control). Personal control and treatment control are strongly
related, and less conﬁdence in the effect of treatment (treatment
control) is also related to a stronger belief in the chronic course of
FM (timeline acute/chronic) and to not understanding the illness
and its symptoms well (illness coherence).
In the ﬁrst column of Table 5, scores in our study population are
presented. Out of 14 possible symptoms, participants with FM
endorse almost six as being directly related to their illness (illness
identity). The high score on timeline acute/chronic indicates that
participants perceive their illness and symptoms to last for a long
time or even for ever. FM patients believe their symptoms to
ﬂuctuate over time (timeline cyclical) and believe their illness to
have a severe impact on physical, social, and psychological
functioning (consequences). They think there is a lot they can
do themselves to control their symptoms and the course of theirillness (personal control). According to the high score on treatment
control, participants with FM also think that treatment can be
effective in decreasing symptoms and curing their illness. The
score on illness coherence is low in participants with FM,
indicating that they do not have a clear picture of their condition.
They do not reportmany negative emotions generated by their FM,
such as getting angry, anxious or depressed (emotional repre-
sentations).
From the 24 comparisons made between FM, CFS, RA and CHD
patients, 17 are signiﬁcantly different. Between FM and coronary
heart patients no comparable score was found at all. Some of them
reﬂect stronger held beliefs andmore positive thoughts in CHD, for
example about the chronicity and controllability of the illness,
while amongst others their condition is more puzzling to CHD
patients and is believed to have more emotional representations.
Both CFS and RA patients endorse more symptoms as being part of
their illness and belief their condition to have more negative
consequences than FM patients, but are more likely to think their
symptoms will pass in time. Illness coherence is best in
Table 3b
Cronbach’s alphas and corrected correlations (Multiple GroupMethod) of the items
in the attributional domains of IPQ-R FM-Dlv
Total Causes domain a = 0.78 1. 2. 3. 4.
1. Sub domain psychological attributions a = 0.86, a = 0.82
Stress or worry 0.431 0.111 0.065 0.155
My mental attitude e.g. thinking
about life negatively
0.418 0.227 0.094 0.016
Family problems or worries
caused my illness (my FM)
0.516 0.204 0.134 0.074
Overwork 0.383 0.196 0.167 0.022
My emotional state e.g. feeling
down, lonely, anxious, empty
0.531 0.210 0.221 0.000
My personality 0.358 0.215 0.115 0.061
2. Sub domain risk factors a = 0.77, a = 0.55
Hereditary—it runs in my family 0.097 0.104 0.001 0.042
Diet or eating habits 0.199 0.203 0.310 0.075
Poor medical care in my past 0.199 0.179 0.438 0.173
My own behaviour 0.422 0.128 0.040 0.008
Ageing 0.165 0.135 0.154 0.065
Smoking 0.136 0.268 0.114 0.281
Alcohol 0.139 0.255 0.143 0.263
3. Sub domain immunity a = 0.67, a = 0.62
A germ or virus 0.111 0.151 0.430 0.096
Pollution in the environment 0.150 0.269 0.387 0.174
Altered immunity 0.136 0.094 0.344 0.081
4. Sub domain Accident or chance a = 0.23, a = 0.14
Chance or bad luck 0.137 0.017 0.108 0.065
Accident or injury 0.068 0.238 0.126 0.065
Cronbach’s alphas in italic script are from the IPQ-R English language version in a
mixed patient group (Moss-Morris et al. [28]), Cronbach’s alphas in bold script from
the IPQ-R FM-Dlv, the highest corrected correlations are presented in bold script.
M.W. van Ittersum et al. / Patient Education and Counseling 74 (2009) 53–60 57rheumatoid arthritis patients compared to all three other patient
groups.
In the causal domain, stress/worries, bad luck, heredity,
problems with immune system and personality are the attribu-
tions to which FM participants strongly agree. Patients with
coronary heart disease think heredity or other biological factors
(35%, n = 279), stress (36%, n = 289) and lifestyle (29%, n = 230) are
most likely to cause their illness [33]. Both CFS and RA patients
think their illness is caused by a germ or immune dysfunction and
by psychological factors [32].
4. Discussion and conclusion
4.1. Discussion
The internal consistency for use of the questionnaire on group
level is acceptable. Also the validity of the items in the illnessTable 4
Pearson’s correlation coefﬁcients of the original IPQ-R English language version and th
1 2 3 4 5
1. Illness Identity 0.05 0.09* 0.07 0.14**
2. Timeline acute/chronic 0.13 0.14** 0.51** 0.29**
3. Timeline cyclical 0.15 0.18 0.24** 0.11**
4. Consequences 0.34** 0.42** 0.04 0.25**
5. Personal control 0.36** 0.10 0.04 0.19
6. Treatment control 0.24* 0.37** 0.03 0.26* 0.63*
7. Illness coherence 0.04 0.13 0.04 0.07 0.19
8. Emotional representations 0.26** 0.11 0.07 0.53* 0.23*
9. Psychological attributions 0.05 0.04 0.16** 0.14 0.24**
10. Risk factor attributions 0.10 0.05 0.15** 0.12 0.12
11. Immune attributions 0.21** 0.05 0.02 0.27** 0.05
12. Chance attributions 0.12 0.04 0.18* 0.04 0.19**
*p < 0.05, **p < 0.01; Results of the IPQ-R English language version (from: Moss-Morriidentity domain was afﬁrmed. However, for three sub domains
within the causes domain no acceptable internal consistency was
found. The sub domain accident or chance presented with a
particularly low Cronbach’s alpha, in our analysis as well as in the
analysis of the IPQ-R English language version. This sub domain
consists of only two items, which probably is not sufﬁcient to form
a separate domain of the questionnaire. Also the two itemsmay not
ﬁt together in a single domain as the content and meaning of
chance or bad luck is different to that of an Accident or injury as
possible cause for illness.
Although MGM revealed that for most domains a priori
assignment of items was supported, the domain structure of the
‘beliefs’ domains as suggested for the original IPQ-R could not be
completely afﬁrmed in our study. In the Dutch IPQ-R the personal
control and treatment control domains might represent a single
control domain. The strong correlation between these two
domains seems to support this assumption. One item that was a
priori assigned to the emotional representations domain correlates
stronger with the consequences domains, two domains that also
have a strong inter domain correlation indicating that these
domains have a lot in common or share an underlying dimension.
Maybe it would be better to combine high correlating domains or
to remove the items of one of these domains.
The expected assignment of the items in the causes sub
domains was not supported by our data. Several items that were a
priori assigned to the risk factor and accident or chance sub
domains correlated strongest with several other sub domains.
Although Pearson’s correlation coefﬁcients of the IPQ-R FM
appear to show inter-relationships as expected between the
domains, not all associations were in accordance with those found
for the original IPQ-R. In the Dutch version only 14 interrelation-
ships between the domains were moderate or high (r  .25),
compared to 24 in the English version. Especially in the illness
identity and illness coherence, and also in some attributional
domains, correlationswere found to differmore than 0.20 between
the two versions of the questionnaire. These differences might be
caused by lacking a known cause and cure and clear symptoms in
FM while in most of the illnesses in the mixed patient group
pathophysiology and sometimes even treatment strategies are
clear.
Moss-Morris et al. [28] calculated psychometric properties of
the IPQ-R English language version for a mixed patient group
consisting of 711 patients with rheumatoid arthritis, type II
diabetes, asthma, chronic pain, acute pain, multiple sclerosis,
myocardial infarction and HIV. Comparison of the psychometric
properties of the questionnaires should ideally be calculated in a
comparable patient group. To our knowledge data for the IPQ-R for
ﬁbromyalgia are not available.e IPQ-R FM-Dlv domains
6 7 8 9 10 11 12
0.13** 0.18* 0.04 0.26** 0.13** 0.31** 0.01
0.42** 0.29** 0.21** 0.01 0.07 0.25** 0.06
0.10** 0.16** 0.30** 0.24** 0.16** 0.25** 0.02
0.32** 0.28** 0.53** 0.07 0.05 0.28** 0.01
0.61** 0.56** 0.20** 0.11** 0.27** 0.08 0.12**
0.74** 0.16** 0.11** 0.33** 0.13** 0.06
0.30* 0.43* 0.06 0.26** 0.08 0.11*
0.20 0.24** 0.21** 0.09* 0.13** 0.16**
0.24** 0.14 0.06 0.64** 0.43** 0.07
0.02 0.21** 0.02 0.50** 0.28** 0.04
0.11 0.17* 0.16 0.24** 0.37** 0.19**
0.20* 0.16 0.20 0.05 0.30* 0.20**
s et al. [29]) are presented above the diagonal.
Table 5
Comparison of Illness perceptions of patients with ﬁbromyalgia, chronic fatigue syndrome, rheumatoid arthritis and coronary heart disease
Domain (min. –max.) FM Mean (S.E.) CFSa Mean (S.E.) 95% CI FM-CFS RAa Mean (S.E.) 95% CI FM-RA CHDb Mean (S.E.) 95% CI FM-CHD
Illness identity (0–14) 5.8 (0.2) 9.3 (0.5) 4.37 to 2.63* 7.3 (0.4) 2.28 to .723* 3.23 (0.1) 2.11 to 2.85*
Timeline acute/chronic (6–30) 25.7 (0.4) 20.1 (0.7) 4.14 to 7.06* 23.4 (0.6) 1.01 to 3.59* 22.5 (0.2) 2.44 to 3.96*
Timeline cyclical (4–20) 14.8 (0.2) 14.1 (0.5) 3.31 to 1.73 13.8 (0.4) .117 to 1.88* 10.5 (0.1) 3.77 to 4.83*
Consequences (6–30) 19.5 (0.4) 24.5 (0.7) 6.58 to 3.42* 21.4 (0.6) 3.28 to .522* 18.2 (0.2) .429 to 2.17*
Personal control (6–30) 21.1 (0.4) 22.1 (0.7) 2.51 to .514 20.0 (0.5) .149 to 2.35 22.0 (0.1) 1.51 to .288*
Treatment control (5–25) 16.4 (0.3) 16.8 (0.5) 1.75 to .953 16.7 (0.4) 1.44 to .838 17.9 (0.1) 2.01 to .990*
Illness coherence (5–25) 15.1 (0.2) 15.6 (0.8) 1.58 to .580 16.8 (0.6) 2.66 to .745* 12.7 (0.1) 1.76 to 3.04*
Emotional representations (6–30) 15.2 (0.4) 17.9 (0.8) 4.35 to 1.05* 15.9 (0.6) 2.08 to .680 16.6 (0.2) 2.22 to .579*
FM = Fibromyalgia; CFS = Chronic Fatique Syndrome; RA = Rheumatoid Arthritis; CHD = Coronary Heart Disease; 95% CI = 95% conﬁdence intervals.
* Indicates a statistically signiﬁcant difference between the means.
a From: Moss-Morris and Chalder [32].
b From: Byrne et al. [33].
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tions of the questionnaires found in our study could be caused by
these disease differences. A high correlation between personal
control and treatment controlwas found; as there is no known cure
for ﬁbromyalgia, treatment should focus on self-management and
self efﬁcacy of patients instead of curation of the disease. This
could explain the strong relation between personal control and
treatment control in FM patients. For the attributional items this
may play an even bigger role, as attributions are probably disease
speciﬁc. Heredity or diet for instance may be adequate as possible
cause in some illnesses but not in others, and therefore be likely to
result in different sub domains.
Other studies that used the IPQ suggest labeling of factors in the
causal domain as: psychological stress cause, biological cause and
behavioral cause. Possibly this distribution, or a division in internal
and external attributions might ﬁt better in patients with
ﬁbromyalgia. In future research the psychometric properties of
the questionnaire should be studied more closely.
The ﬁrst column of Table 5 shows the illness perceptions of the
FM participants. In the description of the original IPQ-R English
language version the interpretation of scores is presented as ‘high
scores on the identity, timeline, consequences, and cyclical
dimensions represent strongly held beliefs about the number of
symptoms attributed to the illness, the chronicity of the condition,
the negative consequences of the illness, and the cyclical nature of
the condition. High scores on the personal control, treatment
control and coherence dimensions, represent positive beliefs about
the controllability of the illness and a personal understanding of
the condition’.
The description does not include when scores should be
interpreted as being high or low, no cut off point is provided. This
makes it difﬁcult to draw conclusions about the illness perceptions
of our participants. Comparing results of our study with results of
patients in other groups, can make it easier to interpret illness
perceptions in patients with ﬁbromyalgia.
In the last couple of years, researchers have been discussing
whether or not ﬁbromyalgia and chronic fatigue syndrome are
interrelated or even interchangeable syndromes. Chronic fatigue
syndrome and ﬁbromyalgia are clinical conditions characterized
by a variety of nonspeciﬁc symptoms including prominent fatigue,
pain, and sleep disturbances. There are no diagnostic studies or
widely accepted, pathogenic, explanatorymodels for either illness.
Despite remarkably different diagnostic criteria, ﬁbromyalgia and
chronic fatigue syndrome have many demographic and clinical
similarities [36–39]. The results of our study may represent that
illness perceptions of patients with ﬁbromyalgia and patients with
chronic fatigue syndrome are comparable on the timeline cyclical,
personal control, treatment control and illness coherence domains,
but that patients with FM attribute less symptoms to their illness,
perceive their illness to be more chronic, and attribute lessnegative consequences to their illness compared to patients with
chronic fatigue syndrome.
As in ﬁbromyalgia, patients with rheumatoid arthritis and
coronary heart disease also present with pain, fatigue and physical
disability. The diseases differ in that for RA and CHD pathophy-
siological backgrounds and pathologic processes are better
understood. Therefore, one might expect more negative percep-
tions and attributions of their illness in patients with FM, where
etiology is unclear. Our study did show statistically signiﬁcant
different scores on most domains of the questionnaire, but some
scores of FM participants are higher and some are lower than in the
other illnesses, not conﬁrming this expectation. Apparently, what
is known about pathology, etiology and consequences in literature
and by health professionals does not strongly relate to patients’
illness perceptions. This is of importance as Gassner et al. [40]
found that in myocardial infarction patient models of their illness
are different from those used by health professionals, and that
participation and adherence to rehabilitation programs are likely
to be improved by strategies that take into consideration patients’
beliefs about their illness.
The differences in illness perceptions found in the comparison
between patients with FM, CFS, RA and CHD might be confounded
by several factors. The illness perception scores of Dutch patients
with ﬁbromyalgia were compared to the scores of English (CFS and
RA) and Irish (CHD) patients. Language difference could be a
confounding factor, as well as cultural differences, climate
differences, and differences in health care systems between the
countries. In a Dutch study by Botha-Scheepers et al. [41] the IPQ-R
was used in patients with osteoarthritis. In their study, median
scores on the domains were calculated. Compared to median
scores in our study, their scores are higher on illness coherence,
identical on timeline cyclical, and lower on all other domains of the
questionnaire. This indicates that patients in our study reported
less understanding of their illness, see the course of their illness as
more chronic, report more symptoms as being related to their
illness, see more negative consequences and emotional represen-
tations because of their FM, but report also more expected control
of treatment or personal interventions in managing the illness.
Validity of the questionnaire should be conﬁrmed in the different
languages and patient groups to be able to draw conclusions.
There are someweaknesses in the design of this study. First, it is
possible that a selection-bias occurred. Patientswere selected from
a treatment center, so all participants have been seeking help in the
past. From 322 patients, 196 agreed to participate. Patients who
agreed to participate may be different in some aspects to those
who did not agree. Unfortunately, it was not possible to compare
respondents and non-respondents. Also all ﬁbromyalgia patients
in our study received some kind of treatment for their ﬁbromyal-
gia. The contents, frequency, duration, intensity and effects of this
treatment and when it was received is unknown. Finally, results
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[32] and Byrne et al. [33]. For gender, age and length of illness we
were able to calculate 95% conﬁdence intervals between the
different groups. The proportion females in the other three study
populations differed signiﬁcantly from the FM group; our study
population consisted of 88% female participants, which is
comparable to other FM studies. Some of the other characteristics
were signiﬁcantly different as well, not all relevant socio-
demographic and illness related variables were known and it
was not possible to control for in the analyses. These factors might
have inﬂuenced illness perceptions andmake the scores difﬁcult to
interpret.
4.2. Conclusion
The internal consistency for most of the domains of the Revised
Illness Perception Questionnaire for Fibromyalgia Dutch language
version (IPQ-R FM-Dlv) is good and appears to show inter-
relationships as expected in FM. Domain and sub domain structure
as presented in the original IPQ-R English language version in a
mixed patient group is largely comparable but could not be
afﬁrmed completely.
Participants with FM have negative beliefs about the con-
sequences of FM on daily living and a lack of understanding of FM
and associated symptoms, and a strong belief in the chronic and
cyclical nature of the condition. FM patients and patients with
chronic fatigue syndrome and rheumatoid arthritis show simila-
rities in their beliefs about the controllability of their illness, but
overall more statistical signiﬁcant differences than similarities
were found between the illness perceptions of patients with FM as
assessed with the Dutch questionnaire and the illness perceptions
of CFS, RA and CHD patients as assessed with the original English
questionnaire.
4.3. Practice implications
This study conﬁrmed that the IPQ-R English language version
can be adapted and used in a sample of ﬁbromyalgia patients. The
Dutch language version for ﬁbromyalgia showed acceptable
internal consistency of the domains, validity of the symptoms in
the illness identity domain and inter-relationships as expected
between all domains of the questionnaire. Future research should
address the factor structure of the control domains and sub
domainswithin the causal domain, and also internal consistency of
these sub domains.
The illness perceptions in patients with ﬁbromyalgia were
shown. These are of particular importance since effective self-
management programs aim at helping patients understand and
reframe the thoughts, beliefs, and expectations about their
symptoms [42–44]. The IPQ-R FM could be a useful instrument
to assess FM patients’ illness perceptions, before addressing them
in treatment.
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